相似文献/References:
[1]顾军,于泽平.乳腺癌内分泌治疗的困惑与展望[J].中华乳腺病杂志(电子版),2014,8(6):378.
[2]盛湲,李恒宇.从单细胞水平看肿瘤异质性[J].中华乳腺病杂志(电子版),2014,8(6):384.
[J].Chinese Journal of Breast Disease (Electronic Version),2014,8(3):384.
[3]路洪超,耿翠芝.BCAR1/p130Cas蛋白与乳腺癌抗雌激素药物耐药的相关研究[J].中华乳腺病杂志(电子版),2007,1(1):80.
LU Hong-chao,GEGN Cui-zhi.Association of BCAR1/p130Cas protein and breast cancer antiestrogen resistance[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(3):80.
[4]张炳先,吴秀萍,蔡明勇.Ⅰ、Ⅱ期乳腺癌１３２例的治疗体会[J].中华乳腺病杂志(电子版),2007,1(1):90.
ZHANG Bing-xian,WU Xiu-ping,CAI Ming-yong.Expeience of treatmen in 132 canses of stage ⅠandⅡ breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(3):90.
[5]郭燕丽.乳腺肿块得超声诊断进展[J].中华乳腺病杂志(电子版),2007,1(2):42.
GUO Yan-li.Advancement of ultrasonic diagnosis in breast lump[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(3):42.
[6]纪光伟,黄安,吴峰.乳腺根治性活检术（附22例26次手术报告）[J].中华乳腺病杂志(电子版),2007,1(2):61.
JI Guang-wei,HUANG An,WU Feng.Radical biopsy of breast lump[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(3):61.
[7]张保宁,王仲照.国际早期乳腺癌研究进展：第10届圣·加仑乳腺癌会议报道[J].中华乳腺病杂志(电子版),2007,1(3):10.
ZHANG Bao-ning,WANG Zhong-zhao.Research advances in early breast cancer: a report of 10th St Gallen Breast Cancer Comference[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(3):10.
[8]付丽,郎荣刚.病理诊断在乳腺癌保乳手术中的作用[J].中华乳腺病杂志(电子版),2007,1(3):14.
FU Li,LANG Rong-gang.Role of pathological diagnosis on breast conserving surgery for breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(3):14.
[9]王曦,杨名添,谢泽明.乳腺癌血清蛋白质芯片检测在预测乳腺癌预后中的应用[J].中华乳腺病杂志(电子版),2007,1(3):40.
WANG Xi,YANG Ming-tian,XIE Ze-ming.Proteome analysis for the identification of tumor-associated biomarkers to predict cancer prognosis[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(3):40.
[10]孟令华,刘巍,宋丽楠.BCSG1、C erbB 2、VEGF表达与乳腺癌临床病理因素相关性研究[J].中华乳腺病杂志(电子版),2007,1(4):6.
[11]傅建民,周颉,谢建生,等.新辅助化疗对乳腺癌耐药基因ＥＲＣＣ１表达的影响[J].中华乳腺病杂志(电子版),2009,3(1):53.
[12]张嘉庆,程琳,郭嘉嘉.乳腺癌外科治疗中一些争议问题的探讨[J].中华乳腺病杂志(电子版),2010,4(2):121.
[13]肖春花.炎性乳腺癌分子研究及治疗进展[J].中华乳腺病杂志(电子版),2010,4(2):155.
[14]易善永,南克俊,姜丽丽,等.新辅助化疗对乳腺癌患者调节性T细胞的影响[J].中华乳腺病杂志(电子版),2010,4(4):434.
[15]张弛,段学宁.乳腺癌生物标记物表达水平对新辅助化疗疗效的预测价值[J].中华乳腺病杂志(电子版),2010,4(6):712.
[16]孙强.乳腺癌新辅助化疗的实践与思考[J].中华乳腺病杂志(电子版),2011,5(3):266.
[17]周艳,明佳,唐鹏,等.术前新辅助短程密集化疗疗效与乳腺癌受体亚型及组织学类型的关系[J].中华乳腺病杂志(电子版),2011,5(3):283.
[18]余海云,李文萍,郜红艺,等.新辅助化疗疗效与乳腺癌Ki67、P53表达的关系[J].中华乳腺病杂志(电子版),2011,5(3):297.
[19]杨后圃,王殊.应用高通量生物技术预测乳腺癌新辅助化疗敏感性研究进展[J].中华乳腺病杂志(电子版),2011,5(3):337.
[20]刘晶晶,张瑾.乳腺癌新辅助化疗研究进展[J].中华乳腺病杂志(电子版),2012,6(1):67.